Found: 16
Select item for more details and to access through your institution.
Nivolumab-induced hepatitis: A rare side effect of an immune check point inhibitor.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 2, p. 459, doi. 10.1177/1078155219837342
- By:
- Publication type:
- Article
Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-12260-3
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes by Age in Metastatic Urinary Tract Cancer: A Retrospective Tertiary Cancer Center Analysis.
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2143, doi. 10.3390/cancers16112143
- By:
- Publication type:
- Article
Enhancing Triage Efficiency and Accuracy in Emergency Rooms for Patients with Metastatic Prostate Cancer: A Retrospective Analysis of Artificial Intelligence-Assisted Triage Using ChatGPT 4.0.
- Published in:
- Cancers, 2023, v. 15, n. 14, p. 3717, doi. 10.3390/cancers15143717
- By:
- Publication type:
- Article
Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 7, p. e2423186, doi. 10.1001/jamanetworkopen.2024.23186
- By:
- Publication type:
- Article
Treatment Patterns and Attrition With Lines of Therapy for Advanced Urothelial Carcinoma in the US.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e249417, doi. 10.1001/jamanetworkopen.2024.9417
- By:
- Publication type:
- Article
Everolimus and Bevacizumab in the Management of Recurrent, Progressive Intracranial NF2 Mutated Meningioma.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 126, doi. 10.1159/000496984
- By:
- Publication type:
- Article
Clinical, Genomic, and Transcriptomic Characteristics of Patients with Metastatic Renal Cell Carcinoma Who Developed Thromboembolic Events.
- Published in:
- Journal of Kidney Cancer & VHL, 2024, v. 11, n. 3, p. 1, doi. 10.15586/jkcvhl.v11i3.319
- By:
- Publication type:
- Article
Detection of BRCA1 , and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting.
- Published in:
- Biomedicines, 2022, v. 10, n. 12, p. 3170, doi. 10.3390/biomedicines10123170
- By:
- Publication type:
- Article
Natural course of metastatic castration‐resistant prostate cancer in the era of intensified androgen deprivation therapy in the hormone‐sensitive setting.
- Published in:
- Prostate, 2024, v. 84, n. 9, p. 888, doi. 10.1002/pros.24696
- By:
- Publication type:
- Article
Impact of androgen receptor alterations on cell‐free DNA genomic profiling on survival outcomes in metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2023, v. 83, n. 16, p. 1602, doi. 10.1002/pros.24618
- By:
- Publication type:
- Article
A Phase II Study of Rucaparib Monotherapy in Nonmetastatic, Hormone-Sensitive Prostate Cancer Demonstrating "BRCAness" Genotype (ROAR).
- Published in:
- Oncologist, 2024, v. 29, n. 5, p. 450, doi. 10.1093/oncolo/oyae030
- By:
- Publication type:
- Article
The Management of Metastatic Castrate-Sensitive Prostate Cancer: From Guidelines to Real-World Practice.
- Published in:
- Oncologist, 2023, v. 28, n. 9, p. 746, doi. 10.1093/oncolo/oyad047
- By:
- Publication type:
- Article
Off‐label use of emicizumab in persons with acquired haemophilia A and von Willebrand disease: A scoping review of the literature.
- Published in:
- Haemophilia, 2022, v. 28, n. 1, p. 4, doi. 10.1111/hae.14450
- By:
- Publication type:
- Article
Daratumumab as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e563, doi. 10.1111/hae.14323
- By:
- Publication type:
- Article
Cabozantinib with immune checkpoint inhibitor versus cabozantinib monotherapy in patients with metastatic clear cell renal cell carcinoma progressing after prior immune checkpoint inhibitor.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2621, doi. 10.1002/cncr.35302
- By:
- Publication type:
- Article